Drug Pipeline

Cetrelimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
13
Active Studies
5
Recruiting
2
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-09 NCT02908906
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity…
Enrollment reduced: 413 -> 234 participants
2026-05-15 NCT07525141
A Study of JNJ-1761981 in Participants With Solid Tumors
Recruitment opened
Active Studies by Phase
Phase 3
2
Phase 2
4
Phase 1/2
3
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04658862 A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in… Urinary Bladder Neoplasms Active, Not Recruiting
NCT05714202 A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical… Bladder Cancer Active, Not Recruiting
Phase 2
NCT06534190 CD8 PET Imaging in Metastatic Solid Tumours Locally Advanced Solid Tumor Recruiting
NCT04919512 A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants… Urinary Bladder Neoplasms Active, Not Recruiting
NCT04640623 A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in… Urinary Bladder Neoplasms Active, Not Recruiting
NCT03431350 A Study of Niraparib Combination Therapies for the Treatment of Metastatic… Prostatic Neoplasms, Castration-Resistant Active, Not Recruiting
Phase 1/2
NCT03473743 A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial… Urothelial Carcinoma Active, Not Recruiting
NCT05908734 A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With… Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
NCT02908906 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity… Neoplasms Active, Not Recruiting
Phase 1
NCT06116786 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer Carcinoma, Non-small-Cell Lung Recruiting
NCT05818683 A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic… Metastatic Castration-resistant Prostate Neoplasms Recruiting
NCT06311578 A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors Neoplasms Recruiting
NCT07525141 A Study of JNJ-1761981 in Participants With Solid Tumors Neoplasms Recruiting
Sponsors Running Cetrelimab Trials
Disease Areas
Get alerts when Cetrelimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free